2022年12月最新中科院JCR期刊分区表数据（升级版）已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | International Journal of Nanomedicine INT J NANOMED LetPub评分 7.6
65人评分
我要评分
声誉 8.0 影响力 6.8 速度 8.9 | |||||||||||||||||||||||||||||||||||||
| 期刊ISSN | 1178-2013 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||||||||||
| P-ISSN | 1176-9114 | |||||||||||||||||||||||||||||||||||||
| 2021-2022最新影响因子 （数据来源于搜索引擎） | 7.033 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||||||||
| 2021-2022自引率 | 3.30%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||||||||
| h-index | 100 | |||||||||||||||||||||||||||||||||||||
| CiteScore |
| |||||||||||||||||||||||||||||||||||||
| 期刊简介 | The International Journal of Nanomedicine is an international, peer-reviewed, open-access journal that reports on all aspects of nanotechnology applications throughout the biomedical field. Reflecting the relevance of this emerging and rapidly evolving research field, the aim of this journal is to highlight research and development leading to potential clinical applications of nanoparticles in the diagnostics, prevention and treatment of disease. Specific topics covered in the journal include: Nanodrug delivery and biosensors Regenerative nanomedicine Nanodiagnostics Nanoinformatics Nanotoxicity. | |||||||||||||||||||||||||||||||||||||
| 期刊官方网站 | http://www.dovepress.com/international-journal-of-nanomedicine-journal | |||||||||||||||||||||||||||||||||||||
| 期刊投稿网址 | http://www.dovepress.com/submit_step_1.php | |||||||||||||||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足International Journal of Nanomedicine的语言要求，还能让International Journal of Nanomedicine编辑和审稿人得到更好的审稿体验，让稿件最大限度地被International Journal of Nanomedicine编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ USD2310; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：nanomedicine、nanotechnology 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardBlind peer review | |||||||||||||||||||||||||||||||||||||
| 通讯方式 | DOVE MEDICAL PRESS LTD, PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752 | |||||||||||||||||||||||||||||||||||||
| 出版商 | Dove Medical Press Ltd. | |||||||||||||||||||||||||||||||||||||
| 涉及的研究方向 | NANOSCIENCE & NANOTECHNOLOGY-PHARMACOLOGY & PHARMACY | |||||||||||||||||||||||||||||||||||||
| 出版国家或地区 | NEW ZEALAND | |||||||||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||||||||
| 出版周期 | Quarterly | |||||||||||||||||||||||||||||||||||||
| 出版年份 | 2006 | |||||||||||||||||||||||||||||||||||||
| 年文章数 | 471点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||||||||
| Gold OA文章占比 | 97.31% | |||||||||||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 84.50% | |||||||||||||||||||||||||||||||||||||
| WOS期刊SCI分区 （ 2021-2022年最新版） | WOS分区等级：1区
| |||||||||||||||||||||||||||||||||||||
| 中科院《国际期刊预警 名单（试行）》名单 | 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2022年12月最新升级版） | 点击查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月基础版） |
| |||||||||||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月升级版） |
| |||||||||||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月旧的升级版） |
| |||||||||||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1178-2013%5BISSN%5D | |||||||||||||||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均1.3个月 | |||||||||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 80% | |||||||||||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在International Journal of Nanomedicine顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 | |||||||||||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||||||||||
|
| |
| 中国学者近期发表的论文 | |
| 1. | Superparamagnetic iron oxide nanoparticle-mediated expression of miR-326 inhibits human endometrial carcinoma stem cell growth. Author: Gao Y1, Qian H2, Tang X1, Du X3, Wang G2, Zhang H2, Ye F2, Liu T4. Journal: Int J Nanomedicine. 2019 Apr 18;14:2719-2731. doi: 10.2147/IJN.S200480. eCollection 2019. PubMed DOI |
| 2. | Long-lasting bactericidal activity through selective physical puncture and controlled ions release of polydopamine and silver nanoparticles-loaded TiO2 nanorods in vitro and in vivo. Author: Guan M1,2, Chen Y1, Wei Y3, Song H3, Gao C1, Cheng H4, Li Y1, Huo K5, Fu J3, Xiong W1. Journal: Int J Nanomedicine. 2019 Apr 24;14:2903-2914. doi: 10.2147/IJN.S202625. eCollection 2019. PubMed DOI |
| 3. | Glucose-responsive mesoporous silica nanoparticles to generation of hydrogen peroxide for synergistic cancer starvation and chemistry therapy. Author: Du X1, Zhang T1, Ma G1, Gu X2, Wang G3, Li J1. Journal: Int J Nanomedicine. 2019 Apr 2;14:2233-2251. doi: 10.2147/IJN.S195900. eCollection 2019. PubMed DOI |
| 4. | Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy. Author: Zhang X1, Men K1, Zhang Y1, Zhang R1, Yang L1, Duan X2. Journal: Int J Nanomedicine. 2019 Apr 23;14:2733-2751. doi: 10.2147/IJN.S198747. eCollection 2019. PubMed DOI |
| 5. | IR780-loaded folate-targeted nanoparticles for near-infrared fluorescence image-guided surgery and photothermal therapy in ovarian cancer. Author: Song J1,2, Zhang N1,2, Zhang L2,3, Yi H2, Liu Y1,2, Li Y1, Li X2,4, Wu M2,5, Hao L2,3, Yang Z1, Wang Z2,3. Journal: Int J Nanomedicine. 2019 Apr 18;14:2757-2772. doi: 10.2147/IJN.S203108. eCollection 2019. PubMed DOI |
| 6. | Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy. Author: Riaz MK1, Zhang X1, Wong KH1, Chen H2, Liu Q2, Chen X1, Zhang G1, Lu A1,3, Yang Z1,3. Journal: Int J Nanomedicine. 2019 Apr 24;14:2879-2902. doi: 10.2147/IJN.S192219. eCollection 2019. PubMed DOI |
| 7. | CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation. Author: Ullah A1, Wang K1, Wu P1, Oupicky D1,2, Sun M1. Journal: Int J Nanomedicine. 2019 Apr 26;14:2927-2944. doi: 10.2147/IJN.S171280. eCollection 2019. PubMed DOI |
| 8. | Highly sensitive electron paramagnetic resonance nanoradicals for quantitative intracellular tumor oxymetric images. Author: Chen NT1, Barth ED2,3, Lee TH4, Chen CT5, Epel B2,3, Halpern HJ2,3, Lo LW5,6. Journal: Int J Nanomedicine. 2019 Apr 29;14:2963-2971. doi: 10.2147/IJN.S194779. eCollection 2019. PubMed DOI |
| 9. | A new biosensor detection system to overcome the Debye screening effect: dialysis-silicon nanowire field effect transistor. Author: Chen H1, Zhao X1, Xi Z1, Zhang Y1, Li H1, Li Z1, Shi H1, Huang L1, Shen R1, Tao J1, Wang T1. Journal: Int J Nanomedicine. 2019 Apr 30;14:2985-2993. doi: 10.2147/IJN.S198734. eCollection 2019. PubMed DOI |
| 10. | Pulmonary toxicities from a 90-day chronic inhalation study with carbon black nanoparticles in rats related to the systemical immune effects. Author: Chu C1, Zhou L1, Xie H1, Pei Z2, Zhang M1, Wu M1, Zhang S3, Wang L4, Zhao C5, Shi L6,7, Zhang N1, Niu Y6,7, Zheng Y8, Zhang R1,7. Journal: Int J Nanomedicine. 2019 Apr 30;14:2995-3013. doi: 10.2147/IJN.S198376. eCollection 2019. PubMed DOI |
|
|
  | |
|
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分： | |
同领域作者分享投稿经验：共82条 （包含回复） |
我来分享 |
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2023 中国: LetPub上海分公司 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960
增值电信业务经营许可证：沪B2-20211595
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451
安全保密
